Vascular Dysfunction in Offspring of Assisted Reproduction Technologies
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The prevalence of infertility has been estimated at 9% worldwide. The steadily increasing use of assisted reproductive technologies (ART) has allowed millions of infertile couples to have children. These children make up for 1 to 4% of the population in developed countries. ART involves the manipulation of early embryos at a time when they may be particularly vulnerable to external disturbances. In line with this concept, studies in mice suggest that ART alters the activity of enzymes involved in the regulation of metabolic and cardiovascular homeostasis. Alternatively, infertility itself or the drugs used to stimulate ovulation may have adverse effects on the outcome of the offspring. The safety of ART for long-term health is, therefore, of utmost importance. Among the potential long-term consequences of ART, cardiovascular disease may represent an important candidate, but there is no information.
Preliminary data from our group show that, children born after in vitro fertilization (IVF) present systemic and pulmonary vascular dysfunction at high-altitude when compared to age- and sex-matched control subjects.
Therefore, the major goal of our proposal is to test the hypothesis that apparently healthy children born after ART display vascular dysfunction of both the pulmonary and the systemic circulation.
| Condition | Intervention |
|---|---|
|
Infertility |
Dietary Supplement: Vitamin C and E |
| Study Type: | Interventional |
| Official Title: | Vascular Dysfunction in Offspring of Assisted Reproduction Technologies |
Eligibility| Ages Eligible for Study: | 10 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Offspring of ART
- Healthy
- No medication
- Born at term
Exclusion Criteria:
- Cardio-pulmonary malformations
- Neuro-muscular malformations
- Previous high altitude diseases
Contacts and Locations| Contact: Urs Scherrer, Prof | +4121 314 09 30 | Urs.Scherrer@chuv.ch |
| Contact: Claudio Sartori, Prof | +4121 314 09 30 | Claudio.Sartori@chuv.ch |
| Switzerland | |
| University Hospital | Recruiting |
| Bern, BE, Switzerland, 3000 | |
| Contact: Yves Allemann, Prof Yves.Allemann@insel.ch | |
| University Hospital | Recruiting |
| Lausanne, VD, Switzerland, 1011 | |
| Contact: Urs Scherrer, Prof +4121 314 09 30 Urs.Scherrer@chuv.ch | |
More Information
No publications provided by University of Lausanne Hospitals
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Prof Urs Scherrer, University Hospital Lausanne |
| ClinicalTrials.gov Identifier: | NCT00837642 History of Changes |
| Other Study ID Numbers: | 35/07 |
| Study First Received: | February 4, 2009 |
| Last Updated: | February 4, 2009 |
| Health Authority: | Switzerland: Federal Office of Public Health |
Keywords provided by University of Lausanne Hospitals:
|
Vascular function in offspring of ART |
Additional relevant MeSH terms:
|
Infertility Genital Diseases, Male Genital Diseases, Female Ascorbic Acid Vitamins Antioxidants |
Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Protective Agents Physiological Effects of Drugs Micronutrients Growth Substances |
ClinicalTrials.gov processed this record on May 23, 2013